EP0463004A4 - Metabolic effects of leukaemia inhibitory factor on bone - Google Patents

Metabolic effects of leukaemia inhibitory factor on bone

Info

Publication number: EP0463004A4
Authority: EP; European Patent Office
Prior art keywords: bone; inhibitory factor; metabolic effects; leukaemia inhibitory; leukaemia
Prior art date: 1989-03-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP19900904185

Other versions

EP0463004A1 (en

Inventor

Donald Metcalf

Ian Reginald Reid

Thomas John Martin

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

CSL Innovation Pty Ltd

Original Assignee

Amrad Corp Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-03-07

Filing date

1990-03-06

Publication date

1992-04-01

1990-03-06 Application filed by Amrad Corp Ltd filed Critical Amrad Corp Ltd

1992-01-02 Publication of EP0463004A1 publication Critical patent/EP0463004A1/en

1992-04-01 Publication of EP0463004A4 publication Critical patent/EP0463004A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2093—Leukaemia inhibitory factor [LIF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Nutrition Science (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP19900904185 1989-03-07 1990-03-06 Metabolic effects of leukaemia inhibitory factor on bone Withdrawn EP0463004A4 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
AU3091/89		1989-03-07
AUPJ309189		1989-03-07
AU4742/89		1989-06-15
AUPJ474289		1989-06-15

Publications (2)

Publication Number	Publication Date
EP0463004A1 EP0463004A1 (en)	1992-01-02
EP0463004A4 true EP0463004A4 (en)	1992-04-01

Family

ID=25643646

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP19900904185 Withdrawn EP0463004A4 (en)	1989-03-07	1990-03-06	Metabolic effects of leukaemia inhibitory factor on bone

Country Status (5)

Country	Link
EP (1)	EP0463004A4 (en)
JP (1)	JP3055802B2 (en)
CA (1)	CA2048673A1 (en)
NZ (1)	NZ232826A (en)
WO (1)	WO1990010454A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL97779A (en) *	1990-04-10	2000-01-31	Genentech Inc	Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof
WO1994021272A1 (en) *	1993-03-17	1994-09-29	Amrad Corporation Limited	A method for treating microbial infection in an animal by administering a composition comprising lif and a cytokine
ATE262918T1 (en) *	1999-09-30	2004-04-15	Kaken Pharma Co Ltd	PRODUCTION OF A MEDICATION FOR IMPROVED HEALING OF THE STERNUM AFTER A STERNOTOMY
WO2014138628A1 (en)	2013-03-07	2014-09-12	Case Western Reserve University	Bioadhesive hydrogel
US11273236B2 (en)	2016-09-07	2022-03-15	Case Western Reserve University	Engineered tissue constructs
EP3551199A4 (en) *	2016-12-11	2020-07-22	Case Western Reserve University	COMPOSITIONS AND METHODS FOR MODULATING ENDOCHONDRAL OSSIFICATION AND BONE FORMATION
EP3672650A4 (en)	2017-08-21	2021-05-26	Case Western Reserve University	HYDROGEL FOR TISSUE ENGINEERING AND BIO-PRINTING
US11191871B2 (en)	2018-03-30	2021-12-07	Case Western Reserve University	Particulate coated hydrogel microparticles

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4438032A (en) *	1981-01-30	1984-03-20	The Regents Of The University Of California	Unique T-lymphocyte line and products derived therefrom
US4675295A (en) *	1981-10-28	1987-06-23	Denki Kagaku Kogyo Kabushiki Kaisha	Process for producing subculturable lymphokine-producing human T cell hybridomas
AU609128B2 (en) *	1987-04-02	1991-04-26	Amrad Operations Pty. Limited	Leukaemia-inhibitory factor

1990
- 1990-03-06 CA CA002048673A patent/CA2048673A1/en not_active Abandoned
- 1990-03-06 EP EP19900904185 patent/EP0463004A4/en not_active Withdrawn
- 1990-03-06 JP JP2504497A patent/JP3055802B2/en not_active Expired - Fee Related
- 1990-03-06 WO PCT/AU1990/000092 patent/WO1990010454A1/en not_active Ceased
- 1990-03-07 NZ NZ232826A patent/NZ232826A/en unknown

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF BONE AND MINERAL RESEARCH, vol. 3, no. 6, December 1988, pages 635-645, Mary Ann Liebert, Inc., New York, US; E. ABE et al.: "A differentiation-inducing factor produced by the osteoblastic cell line MC3T3-E1 stimulates bone resorption by promoting osteoclast formation" *
See also references of WO9010454A1 *

Also Published As

Publication number	Publication date
JPH04503958A (en)	1992-07-16
WO1990010454A1 (en)	1990-09-20
JP3055802B2 (en)	2000-06-26
NZ232826A (en)	1992-09-25
EP0463004A1 (en)	1992-01-02
CA2048673A1 (en)	1990-09-08

Publication	Publication Date	Title
EP0285448A3 (en)	1990-08-29	Leukaemia inhibitory factor
GR3020918T3 (en)	1996-11-30	Synergistic tracker
EP0431253A3 (en)	1991-10-16	Cathodic sputtering device
GB8921008D0 (en)	1989-11-01	Skeletal implants
EP0463004A4 (en)	1992-04-01	Metabolic effects of leukaemia inhibitory factor on bone
EP0414548A3 (en)	1991-12-27	Low frequency restorer
GB9004890D0 (en)	1990-05-02	Leukaemia inhibitory factor
GB8925298D0 (en)	1990-08-08	Object tracking
GB2254851B (en)	1995-06-07	Analysis of carbohydrates
GB8921818D0 (en)	1989-11-08	Treatment of carbohydrates
ZA901746B (en)	1991-01-30	Metabolic effects of leukaemia inhibitory factor on bone
GB9010180D0 (en)	1990-06-27	Bone fixator
EP0458063A3 (en)	1992-03-04	Healing equipment
ZA909314B (en)	1991-09-25	Treatment of hsv
GB2235232B (en)	1993-07-28	Shower enclosures
GB8929266D0 (en)	1990-02-28	Tweezers
GB8924829D0 (en)	1990-05-30	Object tracking
IL93939A0 (en)	1990-12-23	Dynamic external fixator
GB2236054B (en)	1993-10-06	Artificial wrist unit
ZA904825B (en)	1991-04-24	Inhibition of potato-sprouting
ZA882277B (en)	1989-07-26	Leukaemia inhibitory factor
GB9112872D0 (en)	1991-07-31	Analysis of carbohydrates
GB9027990D0 (en)	1991-02-13	Analysis of carbohydrates
GB9014182D0 (en)	1990-08-15	Analysis of carbohydrates
ZA909799B (en)	1991-10-30	Bruting of gem-stones

Legal Events

Date	Code	Title	Description
1991-11-15	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1992-01-02	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE
1992-01-29	17P	Request for examination filed	Effective date: 19911204
1992-04-01	A4	Supplementary search report drawn up and despatched	Effective date: 19920207
1992-04-01	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE
1994-03-16	17Q	First examination report despatched	Effective date: 19940126
1994-10-17	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
1994-12-07	18D	Application deemed to be withdrawn	Effective date: 19940607